Clinical trials
Castleman Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 4 |
| Completed | 4 |
| Terminated | 2 |
| Withdrawn | 1 |
| Suspended | 1 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Pennsylvania | 4 |
| National Cancer Institute (NCI) | 2 |
| Case Comprehensive Cancer Center | 1 |
| Castleman Disease Collaborative Network | 1 |
| Centocor, Inc. | 1 |
| Cylene Pharmaceuticals | 1 |
| Hoffmann-La Roche | 1 |
| M.D. Anderson Cancer Center | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| UNC Lineberger Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Castleman Disease | 14 |
| Multiple Myeloma | 3 |
| Sarcoma, Kaposi | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Breast Neoplasms | 2 |
| Hyperplasia | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Neoplasms | 2 |
| Sarcoma | 2 |
| Amyloidosis | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.